Literature DB >> 18078886

Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty.

Nelson Fong Soohoo1, Raj M Vyas, David B Samimi, Ricardo Molina, Jay R Lieberman.   

Abstract

This study examines the responsiveness of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Short Form-36 (SF-36) in patients undergoing total hip arthroplasty. Eighty-nine patients completed the WOMAC and SF-36 preoperatively and postoperatively. Standardized response means (SRMs) and effect sizes (ES) were used to measure responsiveness. Mean follow-up was 17 months. The SRMs for the WOMAC ranged from -0.93 to -1.49, and the ES ranged from -1.02 to -1.53. The SRMs for the SF-36 ranged from 0.22 to 1.64, and the ES ranged from 0.20 to 1.97. The highest values occurred with the physical functioning, bodily pain, and Physical Component Summary Scales. This study demonstrates a similar level of responsiveness of the WOMAC and several components of the SF-36. This suggests that the isolated use of the SF-36 may be adequate to monitor outcomes after total hip arthroplasty. There may still be a role for the WOMAC when comparing outcomes of specific designs or techniques of total hip arthroplasty.

Entities:  

Mesh:

Year:  2007        PMID: 18078886     DOI: 10.1016/j.arth.2006.10.006

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

1.  Factors affecting response rates to mailed preoperative surveys among arthroplasty patients.

Authors:  Wenbao Wang; Jeffrey A Geller; Abraham Kim; Todd A Morrison; Jung Keun Choi; William Macaulay
Journal:  World J Orthop       Date:  2012-01-18

2.  Performance-Based Versus Self-Reported Outcomes Using the Hip Disability and Osteoarthritis Outcome Score After Total Hip Arthroplasty.

Authors:  Michael R Dayton; Dana L Judd; Craig A Hogan; Jennifer E Stevens-Lapsley
Journal:  Am J Phys Med Rehabil       Date:  2016-02       Impact factor: 2.159

3.  Comparison of the responsiveness of the SF-36, the Oxford Knee Score, and the Knee Society Clinical Rating System in patients undergoing total knee replacement.

Authors:  Yu Ko; Ngai-Nung Lo; Seng-Jin Yeo; Kuang-Ying Yang; William Yeo; Hwei-Chi Chong; Julian Thumboo
Journal:  Qual Life Res       Date:  2013-03-05       Impact factor: 4.147

4.  Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery.

Authors:  Heidi Kapstad; Berit Rokne; Knut Stavem
Journal:  Health Qual Life Outcomes       Date:  2010-12-09       Impact factor: 3.186

5.  Responsiveness differences in outcome instruments after revision hip arthroplasty: what are the implications?

Authors:  Jasvinder A Singh
Journal:  BMC Musculoskelet Disord       Date:  2011-05-23       Impact factor: 2.362

6.  Quality of life and functionality after total hip arthroplasty: a long-term follow-up study.

Authors:  Massimo Mariconda; Olimpio Galasso; Giovan Giuseppe Costa; Pasquale Recano; Simone Cerbasi
Journal:  BMC Musculoskelet Disord       Date:  2011-10-06       Impact factor: 2.362

7.  Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change.

Authors:  Jasvinder A Singh; Cathy Schleck; W Scott Harmsen; David G Lewallen
Journal:  BMC Musculoskelet Disord       Date:  2016-01-19       Impact factor: 2.362

8.  Good stability of a cementless, anatomically designed femoral stem in aging women: a 9-year RSA study of 32 patients.

Authors:  Erik Aro; Jessica J Alm; Niko Moritz; Kimmo Mattila; Hannu T Aro
Journal:  Acta Orthop       Date:  2018-07-10       Impact factor: 3.717

9.  Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty.

Authors:  Hannu T Aro; Sanaz Nazari-Farsani; Mia Vuopio; Eliisa Löyttyniemi; Kimmo Mattila
Journal:  JBMR Plus       Date:  2019-08-14

10.  Persisting inter-limb differences in patients following total hip arthroplasty four to five years after surgery? A preliminary cross-sectional study.

Authors:  Stefanie John; David Weizel; Anna S Heumann; Anja Fischer; Katja Orlowski; Kai-Uwe Mrkor; Jürgen Edelmann-Nusser; Kerstin Witte
Journal:  BMC Musculoskelet Disord       Date:  2021-02-27       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.